fbpx ESAIC

COVID-19 Webinar Series: 5th Episode

ESAIC Webinar 5 COVID-19

Bookmark the link above

Webinar on COVID-19 5th Episode: Sedation, Fluids and Transfusion, Haemostasis and Thrombosis

Date: Tuesday, 26 May 2020

Time: 18:00 – 19.00 CEST (17.00 – 18.00 BST)




Meet our Scientific Faculty

Scientific Faculty Leader and Scientific Support

Prof. Dr Marcelo Gama de Abreu 

Department of Anesthesiology and Intensive Care 

University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany 



Prof. Dr Ilona Bobek 

Department of Anaesthesiology and Intensive Care MedicineBudapest, Hungary 


Prof. Dr Vincent Bonhomme 

University Department of Anesthesia and Intensive Care Medicine, CHR Citadelle and CHU Liege, Liege, Belgium


Prof. Dr Thomas Scheeren 

Department of Anesthesiology, University Medical Center Groningen, the Netherlands 


Prof. Dr Marc Samama 

Department of Anaesthesiology & Intensive Care, Cochin University Hospital, France


Target Audience 

All caregivers involved in anaesthesia, intensive care and critical emergency medicine, including physicians and non-physicians 

Key points of this webinar:  

  • Monitoring of sedation and pain relief
  • Fluid and transfusion management  
  • Haemostasis, thrombosis and anticoagulation 

Learning Objectives:
This webinar will enable caregivers of patients with COVID-19 to: 

  • Choose appropriate sedation techniques and monitoring  
  • Conduct and monitor fluid and transfusion on an individual basis and according to pathophysiological particularities 
  • Describe disease-specific implications for haemostasis and thrombosis, and apply differentiated algorithms for phophylaxis and treatment   

Practical skills to be acquired after attending this Webinar
The user can:  

  • Conduct most appropriate sedation techniques in this population 
  • Guide fluid and transfusion therapy that is tailored to individual needs 
  • Diagnose and manage the hypercoagulable status 

Affective skills acquired after attending to this Webinar:
The user is aware of: 

  • Objective and safe handling in this population 
  • Unique needs of COVID-19 
  • Expert recommendations based on pathophysiological rationales and clinical experience 

Supported by

Sponsored by